Ruzbeh Mosadeghi

Ruzbeh Mosadeghi practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Ruzbeh Mosadeghi's NPI, 1700319084, was assigned on April 4, 2017. Ruzbeh Mosadeghi graduated from Keck School of Medicine of USC in 2017. Ruzbeh Mosadeghi holds California license A161709.

Ruzbeh Mosadeghi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Ruzbeh Mosadeghi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Ruzbeh Mosadeghi to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ruzbeh Mosadeghi practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Ruzbeh Mosadeghi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Ruzbeh Mosadeghi is board certified in gastroenterology by the American Board of Internal Medicine. Ruzbeh Mosadeghi is licensed in California.

Dmand AI lists colonoscopy and irritable bowel syndrome (IBS) among the conditions Ruzbeh Mosadeghi treats.

CMS data shows 126 Medicare services from Ruzbeh Mosadeghi across 6 procedure codes in 2024, for 96 Medicare patients. Medicare paid $14,432 for them.

CMS counts 96 Medicare patients who saw Ruzbeh Mosadeghi in 2024. The largest group is 65 to 74, with 40 patients. 69% of them have high cholesterol, and 64% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ruzbeh Mosadeghi's median patient age at 60, with 45% women.

In 2024, Ruzbeh Mosadeghi wrote 56 Medicare Part D claims for 19 patients. 61% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $194 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Ruzbeh Mosadeghi for performance year 2024, reported as part of a group. Ruzbeh Mosadeghi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ruzbeh Mosadeghi as offering telehealth. CMS counts 28 procedures of colonoscopy by Ruzbeh Mosadeghi, more than 53% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Ruzbeh Mosadeghi, published from 2012 to 2016. 2012 was the busiest year, with 2. The most frequent topics are Cullin Proteins, Kinetics and NEDD8 Protein.

CMS Open Payments shows 1 general payment to Ruzbeh Mosadeghi from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $112.

Dmand AI lists 1 award for Ruzbeh Mosadeghi, most recently Rainin Scholar in 2023.

Ruzbeh Mosadeghi graduated from Keck School of Medicine of USC in 2017. Ruzbeh Mosadeghi is a member of ACG and AGA.

Ruzbeh Mosadeghi is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.